- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
House Votes Again to Repeal Health Law
WASHINGTON — One by one, they queued up in the aisles of the House of Representatives, eager for their one minute to unload on President Obama’s signature legislative achievement.
For many Republicans, this was one of the major reasons for coming to Washington in the first place. And they were not going to miss their chance — whether it was their 37th time voting to repeal the 2010 health care overhaul, or their first.
“Obamacare is enforced by the I.R.S., probably the most feared federal agency in the United States government,” said Representative Michele Bachmann of Minnesota, offering one of the newest and more novel reasons Americans should fear the law. The dreaded Internal Revenue Service, she said, had just been caught targeting people from all walks of life: Christians, friends of Israel, people for less debt and more jobs, to name a few.
Read the full story here: http://nyti.ms/17EsHbe
Source: The New York Times
Health Equity and Access Weekly Roundup: May 11, 2024
May 11th 2024This week's topics include frameworks for improving health equity nationwide, addressing social determinants of health, discussing CMS's Medicare rules, investigating breast cancer treatment refusal, and exploring HIV and major depressive disorder in underrepresented groups.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More
